Outside Publication

Medtech Patents in China: New Guidance from China, Life Science Leader

February 2020

Morgan Lewis partners Shaobin Zhu and Nathan Smith and associate Jensen Xu authored a Life Science Leader article about the amendment to the China Guidance for Patent Examination that took effect on Nov. 1, 2019. In the article, they discussed changes to prosecution in China and key takeaways for medtech companies.

Read the full Life Science Leader article >>